Search Within

William Douglas Tap

Formats
  1. Journal Article (191)
  2. Meeting Abstract (159)
  3. Review (11)
  4. Book Section (4)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (2)
  8. Research Letter (1)
Groups
  1. Department of Medicine (375)
  2. Sarcoma Service (375)
  3. Solid Tumor Oncology Division (375)
  4. GSK Faculty (158)
  5. Tow Center for Developmental Oncology (TCDO) (148)
  6. Department of Pathology and Laboratory Medicine (132)

More Groups

People
  1. Sandra D'Angelo (105)
  2. Cristina Antonescu (96)
  3. Mark Dickson (91)
  4. Samuel Singer (80)
  5. Mrinal Gounder (78)
  6. Mary Keohan (76)

More People

Years
  1. 2025 (17)
  2. 2024 (50)
  3. 2023 (34)
  4. 2022 (43)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Annals of Oncology (30)
  3. Clinical Cancer Research (27)
  4. Cancer Research (14)
  5. Modern Pathology (11)
  6. Lancet Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (109)
  2. American Association for Cancer Research (48)
  3. Oxford University Press (38)
  4. Elsevier Science, Inc. (22)
  5. Elsevier Inc. (20)
  6. Nature Publishing Group (19)

More Publishers

Results (375)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [RETRACTED] Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
    Journal Article

    Chang, K. K.; Yoon, C.; Yi, B. C.; Tap, W. D.; Simon, M. C.; Yoon, S. S.
    Oncogenesis (2018)

    Fulltext@MSK | Save
  • Mechanistic understanding of the role of ATRX in senescence provides new insight for combinatorial therapies with CDK4 inhibitors
    Journal Article

    Kovatcheva, M.; Klein, M. E.; Tap, W. D.; Koff, A.
    Molecular & Cellular Oncology (2018)

    Fulltext@MSK | Save
  • Trametinib in histiocytic sarcoma with an activating MAP2K1 (MEK1) mutation - To the editor
    Journal Article

    Gounder, M. M.; Solit, D. B.; Tap, W. D.
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save
  • Soft tissue sarcoma, version 2.2018: Clinical Practice Guidelines in Oncology
    Journal Article

    von Mehren, M.; Randall, R. L.; Benjamin, R. S.; Boles, S.; Bui, M. M.; Ganjoo, K. N.; George, S.; Gonzalez, R. J.; Heslin, M. J.; Kane, J. M. 3rd; more...
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Journal Article

    Chiang, S.; Cotzia, P.; Hyman, D. M.; Drilon, A.; Tap, W. D.; Zhang, L.; Hechtman, J. F.; Frosina, D.; Jungbluth, A. A.; Murali, R.; more...
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • Senescence after growth arrest: A mechanism by which CDK4/6 inhibitors can mediate their activity suppressing tumor progression
    Meeting Abstract

    Koff, A.; Klein, M. E.; Dickson, M. A.; Antonescu, C.; Qin, L. X.; Dooley, S. J.; Schwartz, G.; Crago, A. M.; Singer, S.; Tap, W. D.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): Two open-label, non-comparative, randomised, phase 2 trials
    Journal Article

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Atkins, J.; Milhem, M. M.; Jahagirdar, B. N.; Antonescu, C. R.; Horvath, E.; Tap, W. D.; Schwartz, G. K.; more...
    Lancet Oncology (2018)

    Fulltext@MSK | Save
  • CDK4 inhibition and senescence: Pathway understanding leads to rational drug combinations
    Meeting Abstract

    Klein, M. E.; Kovatcheva, M.; Dickson, M. A.; Liu, D.; Crago, A. M.; Schwartz, G. K.; Tap, W. D.; Singer, S.; Koff, A.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Locally aggressive connective tissue tumors
    Journal Article

    Gounder, M. M.; Thomas, D. M.; Tap, W. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Open label, non-randomized, multi-cohort pilot study of genetically engineered NY-ESO-1 specific NY-ESO-1 (c259)t in HLA-A2(+) patients with synovial sarcoma (NCT01343043)
    Meeting Abstract

    Mackall, C.; Tap, W. D.; Glod, J.; Druta, M.; Chow, W. A.; Araujo, D. M.; Grupp, S. A.; Van Tine, B. A.; Chagin, K.; Van Winkle, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save